Leiomyosarcoma differential diagnosis

Leiomyosarcoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Leiomyosarcoma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Leiomyosarcoma differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Leiomyosarcoma differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Leiomyosarcoma differential diagnosis
CDC on Leiomyosarcoma differential diagnosis
Leiomyosarcoma differential diagnosis in the news
Blogs on Leiomyosarcoma differential diagnosis
Directions to Hospitals Treating Leiomyosarcoma
Risk calculators and risk factors for Leiomyosarcoma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]

Overview

Leiomyosarcoma must be differentiated from other soft tissue tumors, some variants of leimyoma resembles malignant tumor. Other possible differential diagnosis of leimyosarcoma include, epithelioid endometrial stromal sarcoma, alveolar soft part sarcoma, epithelioid angiosarcoma, pleomorphic rhabdomyosarcoma.

Differentiating Leiomyosarcoma from other Diseases

The table below summarizes the findings that differentiate Leiomyosarcoma from other conditions that may cause similar signs and symptoms.

Diseases	Clinical manifestations						Para-clinical findings							Gold standard	Additional findings
	Symptoms			Physical examination
							Lab Findings			Imaging			Histology
				Physical exam 1			Lab 1	Lab 2	Lab 3	Imaging 1	Imaging 2	Imaging 3
Leimyoma (mitotically active type)	Vaginal bleeding Pelvic pain						CBC Suggestive of Anemia						Abscence of cytologic atypia Mild nuclear atypia, up to 10-20 mitosis No tumor cell necrosis	Biopsy and histology	-
Hemorrhagic cellular leiomyomas (apoplectic leiomyoma)											-	-	Zones of recent hemorrhage within nodules of hypercellular smooth muscle. Coagulative necrosis (red degeneration) Mitotic figure not exceeding 2/10 HPF, mostly located in the perihemorrhagic areas
Endometrial Cancer	Abnormal Vaginal bleeding or post coital bleeding	Pelvic pain	Dysparunia	Vaginal Bleeding	Enlarged uterus	Lymphadenopathy	CBC and Clotting studies to r/o anemia and coagulopathy	Urine or serum Beta HCG to r/o pregnancy	LFT/ CA-125 can also be done	Thickened endometrial line on ultrasound.	Thickened endometrial line on CT	Thickened endometrial line on MRI	In well-differentiated forms, endometrioid adenocarcinoma produces small, round back-to-back glands without intervening stroma with varying degrees of glandular complexity are demonstrated by luminal infolding, budding, papillae (with or without psammoma bodies), and cribriforming. In grade 1 lesions, nuclei of the lining epithelial cells are uniform and oval to cylindrical, with minimal atypia and small discrete nucleoli. The cellular axes are perpendicular to the basement membrane, and stratification may or may not be present. Typically, high-grade tumors (with significant solid components) display an increased amount of nuclear atypia, as demonstrated by pleomorphism, irregular chromatin clumping, and prominent nucleoli	Biopsy under hysteroscopic guidance	-
	Symptom 1	Symptom 2	Symptom 3	Physical exam 1	Physical exam 2	Physical exam 3	Lab 1	Lab 2	Lab 3	Imaging 1	Imaging 2	Imaging 3	Histopathology	Gold standard	Additional findings
Differential Diagnosis 4
Differential Diagnosis 5
Differential Diagnosis 6